Login
$CRVO
$2.22 -$0.02 (0.89%) Close

$CRVO 8-K SEC Filings

Filed On Filing
14 Oct 2026 8-K: Regulation FD Disclosure

Certain information concerning the business, clinical studies, development plans, financial position, and related matters of CervoMed Inc. (the “Company,” “we,” or “us”) is being made available on our website, www.cervomed.com, under the...

13 Oct 2026 8-K: Regulation FD Disclosure; Other Events

CervoMed Presents Initial Results of Phase 2a Trial of Neflamapimod in Nonfluent Variant Primary Progressive Aphasia (nfvPPA) Showing Positive Effects on a Key Neurodegeneration Biomarker in Late-Breaking Oral Session at ISFTD 2026

09 Oct 2026 8-K: Regulation FD Disclosure

Certain information concerning the business, clinical studies, development plans, financial position, and related matters of CervoMed Inc. (the “Company,” “we,” or “us”) is being made available on our website, www.cervomed.com, under the...

28 Sep 2026 8-K: Regulation FD Disclosure; Other Events

CervoMed Announces Pharmacokinetic Results with New Neflamapimod Oral Tablet Formulation and Secures FDA Removal of Drug Exposure Limit

10 Sep 2026 8-K: Regulation FD Disclosure; Other Events

CervoMed Announces Initial Results from the Phase 2a Clinical Trial of Neflamapimod in Nonfluent Variant Primary Progressive Aphasia (nfvPPA) Have Been Accepted as a Late-Breaking Oral Session at ISFTD 2026

10 Aug 2026 8-K: Results of Operations and Financial Condition
04 Aug 2026 8-K: Regulation FD Disclosure; Other Events
14 Jul 2026 8-K: Regulation FD Disclosure; Other Events
09 Jul 2026 8-K: Regulation FD Disclosure; Other Events
22 Jun 2026 8-K: Regulation FD Disclosure; Other Events
22 Jun 2026 8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more
18 Jun 2026 8-K: Other Events
15 Jun 2026 8-K: Regulation FD Disclosure
10 Jun 2026 8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +2 more
09 Jun 2026 8-K: Submission of Matters to a Vote of Security Holders
18 May 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
22 Apr 2026 8-K: Regulation FD Disclosure; Other Events
07 Apr 2026 8-K: Regulation FD Disclosure
23 Mar 2026 8-K: Regulation FD Disclosure
19 Mar 2026 8-K: Regulation FD Disclosure; Other Events

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support